Beijing Centergate Technologies (Holding) Co (SZSE:000931) EBIT : ¥179 Mil (TTM As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Beijing Centergate Technologies (Holding) Co EBIT?

Beijing Centergate Technologies (Holding) Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥49 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥179 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Beijing Centergate Technologies (Holding) Co's annualized ROC % for the quarter that ended in Sep. 2024 was 4.52%. Beijing Centergate Technologies (Holding) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 10.99%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Beijing Centergate Technologies (Holding) Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 3.86%.

Beijing Centergate Technologies (Holding) Co EBIT Historical Data

The historical data trend for Beijing Centergate Technologies (Holding) Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Centergate Technologies (Holding) Co EBIT Chart

Beijing Centergate Technologies (Holding) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

214.75

137.44

-11.42

57.46

145.81

Beijing Centergate Technologies (Holding) Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial															28.12	37.55	31.57	61.76	48.51

Competitive Comparison of Beijing Centergate Technologies (Holding) Co's EBIT

For the Medical Instruments & Supplies subindustry, Beijing Centergate Technologies (Holding) Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Centergate Technologies (Holding) Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Centergate Technologies (Holding) Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Beijing Centergate Technologies (Holding) Co's EV-to-EBIT falls into.

Beijing Centergate Technologies (Holding) Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥179 Mil.

Beijing Centergate Technologies (Holding) Co (SZSE:000931) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Beijing Centergate Technologies (Holding) Co's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	201.524 * ( 1 - 37.61% )	/	( (2761.79	+	2797.963)	/ 2 )
=	125.7308236	/	2779.8765
=	4.52 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3765.517	-	848.746	-	( 154.981	-	max(0, 1490.22	-	1753.493	+	154.981	))
=	2761.79

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3775.919	-	782.947	-	( 195.009	-	max(0, 1431.219	-	1763.014	+	195.009	))
=	2797.963

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Beijing Centergate Technologies (Holding) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	194.02	/	( ( (1222.66 + max(500.726, 0))	+	(1245.866 + max(562.24, 0)) )	/	2 )
=	194.02	/	( ( 1723.386	+	1808.106 )	/	2 )
=	194.02	/	1765.746
=	10.99 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(968.611	+	285.945	+	190.8)	-	(848.746	+	0	+	95.884)
=	500.726

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(978.135	+	284.096	+	185.772)	-	(782.947	+	0	+	102.816)
=	562.24

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Beijing Centergate Technologies (Holding) Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	179.383	/	4644.887
	=	3.86 %

Beijing Centergate Technologies (Holding) Co EBIT Related Terms

Thank you for viewing the detailed overview of Beijing Centergate Technologies (Holding) Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Centergate Technologies (Holding) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Centergate Technologies (Holding) Co Ltd (SZSE:000931) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 26, Yunyun Road, 2208, 22nd Floor, Block B, Pengrun Building, Chaoyang District, Beijing, CHN, 100016

Website

http://www.centek.com.cn

Beijing Centergate Technologies (Holding) Co Ltd is principally engaged in the biomedicine and health products business, elderly care and medical business, commercial concrete business and other businesses. The company generates majority of its revenue from biomedicine segment.

Executives

Huang Zhi Yu	Directors, executives
Song Xue Wu	Executives
Hou Zhan Jun	Directors, executives
Li Bin	Executives
Dong Guo Ming	Executives
Guo Guang	Independent director
Huang Xiu Hong	Director
Wang Lei	Securities Affairs Representative

Beijing Centergate Technologies (Holding) Co Headlines

No Headlines